My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 213

    1.

    Coexpression of CD25 and OX40 (CD134) receptors delineates autoreactive T-cells in type 1 diabetes.

    Endl J, Rosinger S, Schwarz B, Friedrich SO, Rothe G, Karges W, Schlosser M, Eiermann T, Schendel DJ, Boehm BO.

    Diabetes. 2006 Jan;55(1):50-60.PMID: 16380476 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Kinetic of regulatory CD25high and activated CD134+ (OX40) T lymphocytes during acute and chronic graft-versus-host disease after allogeneic bone marrow transplantation.

    Sanchez J, Casaño J, Alvarez MA, Roman-Gomez J, Martin C, Martinez F, Gomez P, Serrano J, Herrera C, Torres A.

    Br J Haematol. 2004 Sep;126(5):697-703.PMID: 15327522 [PubMed - indexed for MEDLINE]Related articles

    3.

    Identification of a CD4+CD25+ T cell subset committed in vivo to suppress antigen-specific T cell responses without additional stimulation.

    Nolte-'t Hoen EN, Wagenaar-Hilbers JP, Boot EP, Lin CH, Arkesteijn GJ, van Eden W, Taams LS, Wauben MH.

    Eur J Immunol. 2004 Nov;34(11):3016-27.PMID: 15376196 [PubMed - indexed for MEDLINE]Related articles

    4.

    CD25 expression distinguishes functionally distinct alloreactive CD4 CD134 (OX40) T-cell subsets in acute graft-versus-host disease.

    Streeter PR, Zhang X, Tittle TV, Schön CN, Weinberg AD, Maziarz RT.

    Biol Blood Marrow Transplant. 2004 May;10(5):298-309.PMID: 15111929 [PubMed - indexed for MEDLINE]Related articles

    5.

    Antibodies to OX-40 (CD134) can identify and eliminate autoreactive T cells: implications for human autoimmune disease.

    Weinberg AD.

    Mol Med Today. 1998 Feb;4(2):76-83. Review.PMID: 9547794 [PubMed - indexed for MEDLINE]Related articles

    6.

    GAD65-reactive T cells are activated in patients with autoimmune type 1a diabetes.

    Viglietta V, Kent SC, Orban T, Hafler DA.

    J Clin Invest. 2002 Apr;109(7):895-903. Erratum in: J Clin Invest 2002 Jun;109(11):1511. PMID: 11927616 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    T-cell activation marker expression on tumor-infiltrating lymphocytes as prognostic factor in cutaneous malignant melanoma.

    Ladányi A, Somlai B, Gilde K, Fejös Z, Gaudi I, Tímár J.

    Clin Cancer Res. 2004 Jan 15;10(2):521-30.PMID: 14760073 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    [Relationship between OX40/4-1 BB (CD134/CD137) costimulatory molecules expression on T lymphocytes and stimulating and blocking autoantibodies to the TSH-receptor in children with Graves' disease]

    Bossowski A, Stasiak-Barmuta A, Urban M, Rinderle C.

    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2005;11(3):133-40. Polish. PMID: 16232366 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Autoreactive T cell response in CD25-negative fraction of peripheral blood mononuclear cells in established type 1 diabetes.

    Moriyama H, Kotani R, Katsuta A, Kameno M, Arai T, Okumachi Y, Kishi M, Yamada K, Yasuda H, Hara K, Yokono K, Nagata M.

    Ann N Y Acad Sci. 2008 Dec;1150:278-81.PMID: 19120313 [PubMed - indexed for MEDLINE]Related articles

    10.

    Evidence for in vivo primed and expanded autoreactive T cells as a specific feature of patients with type 1 diabetes.

    Monti P, Scirpoli M, Rigamonti A, Mayr A, Jaeger A, Bonfanti R, Chiumello G, Ziegler AG, Bonifacio E.

    J Immunol. 2007 Nov 1;179(9):5785-92.PMID: 17947651 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Activation-associated phenotype of CD3 T cells in acute graft-versus-host disease.

    Paz Morante M, Briones J, Canto E, Sabzevari H, Martino R, Sierra J, Rodriguez-Sanchez JL, Vidal S.

    Clin Exp Immunol. 2006 Jul;145(1):36-43.PMID: 16792671 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Expression of T-cell activation marker CD134 (OX40) in lymphomatoid papulosis.

    Gniadecki R, Rossen K.

    Br J Dermatol. 2003 May;148(5):885-91.PMID: 12786817 [PubMed - indexed for MEDLINE]Related articles

    13.

    T lymphocytes in the synovial fluid of patients with active rheumatoid arthritis display CD134-OX40 surface antigen.

    Giacomelli R, Passacantando A, Perricone R, Parzanese I, Rascente M, Minisola G, Tonietti G.

    Clin Exp Rheumatol. 2001 May-Jun;19(3):317-20.PMID: 11407087 [PubMed - indexed for MEDLINE]Related articles

    14.

    Pro- and anti-inflammatory cytokine production by autoimmune T cells against preproinsulin in HLA-DRB1*04, DQ8 Type 1 diabetes.

    Durinovic-Belló I, Schlosser M, Riedl M, Maisel N, Rosinger S, Kalbacher H, Deeg M, Ziegler M, Elliott J, Roep BO, Karges W, Boehm BO.

    Diabetologia. 2004 Mar;47(3):439-50. Epub 2004 Jan 24.PMID: 14745491 [PubMed - indexed for MEDLINE]Related articles

    15.

    CD134 as target for specific drug delivery to auto-aggressive CD4+ T cells in adjuvant arthritis.

    Boot EP, Koning GA, Storm G, Wagenaar-Hilbers JP, van Eden W, Everse LA, Wauben MH.

    Arthritis Res Ther. 2005;7(3):R604-15. Epub 2005 Mar 21.PMID: 15899047 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Strong expression of CD134 (OX40), a member of the TNF receptor family, in a T helper 2-type cytokine environment.

    Roos A, Schilder-Tol EJ, Weening JJ, Aten J.

    J Leukoc Biol. 1998 Oct;64(4):503-10.PMID: 9766631 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Deficiency in NOD antigen-presenting cell function may be responsible for suboptimal CD4+CD25+ T-cell-mediated regulation and type 1 diabetes development in NOD mice.

    Alard P, Manirarora JN, Parnell SA, Hudkins JL, Clark SL, Kosiewicz MM.

    Diabetes. 2006 Jul;55(7):2098-105.PMID: 16804081 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Molecular mimicry in type 1 diabetes mellitus revisited: T-cell clones to GAD65 peptides with sequence homology to Coxsackie or proinsulin peptides do not crossreact with homologous counterpart.

    Schloot NC, Willemen SJ, Duinkerken G, Drijfhout JW, de Vries RR, Roep BO.

    Hum Immunol. 2001 Apr;62(4):299-309.PMID: 11295462 [PubMed - indexed for MEDLINE]Related articles

    19.

    OX40 (CD134) blockade inhibits the co-stimulatory cascade and promotes heart allograft survival.

    Curry AJ, Chikwe J, Smith XG, Cai M, Schwarz H, Bradley JA, Bolton EM.

    Transplantation. 2004 Sep 27;78(6):807-14.PMID: 15385798 [PubMed - indexed for MEDLINE]Related articles

    20.

    T cell reactivity to human insulinoma cell line (CM) antigens in patients with type 1 diabetes.

    Monetini L, Cavallo MG, Barone F, Valente L, Russo M, Walker B, Thorpe R, Pozzilli P.

    Autoimmunity. 1999;29(3):171-7.PMID: 10433097 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is temporarily unavailable.

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    » See more...